Publications by authors named "Paul Blood"

Claim this Profile
T
Tumor-associated autoantibodies correlate with poor outcome in prostate cancer patients treated with androgen deprivation and external beam radiation therapy.
Lisa Ds Johnson, Nancy J Nesslinger, Paul A Blood, Navraj Chima, Lindsay R Richier

Oncoimmunology· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palliative radiotherapy utilization for cancer patients at end of life in British Columbia: retrospective cohort study.
Jin Huang, Elaine S Wai, Francis Lau, Paul A Blood

BMC Palliat Care· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of quality assurance rounds in a Canadian radiation therapy department.
Shilo Lefresne, Ivo A Olivotto, Howard Joe, Paul A Blood, Robert A Olson

Int J Radiat Oncol Biol Phys· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of combined androgen blockade for advanced prostate cancer in British Columbia.
Adeline Chau, Mário L de Lemos, Tom Pickles, Paul Blood, Laurel Kovacic

J Oncol Pharm Pract· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does neoadjuvant hormone therapy improve outcome in prostate cancer patients receiving radiotherapy after radical prostatectomy?
Howard Huaihan Pai, Brenna Eldridge, Darcy Bishop, Abraham Alexander, Mary Lesperance, Paul Blood

Can J Urol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The median non-prostate cancer survival is more than 10 years for men up to age 80 years who are selected and receive curative radiation treatment for prostate cancer.
Paul A Blood, Tom Pickles

Radiat Oncol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment PSA velocity as a predictor of disease outcome following radical radiation therapy.
David Palma, Scott Tyldesley, Paul Blood, Mitchell Liu, James Morris

Int J Radiat Oncol Biol Phys· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The changing age distribution of prostate cancer in Canada.
C Ineke Neutel, Ru-Nie Gao, Paul A Blood, Leslie A Gaudette

Can J Public Health· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard treatments induce antigen-specific immune responses in prostate cancer.
Nancy J Nesslinger, Robert A Sahota, Brad Stone, Kayli Johnson, Navraj Chima, Paul Blood

Clin Cancer Res· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in prostate cancer incidence, hospital utilization and surgical procedures, Canada, 1981-2000.
C Ineke Neutel, Ru-Nie Gao, Paul A Blood, Leslie A Gaudette

Can J Public Health· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective evaluation of the prevalence and severity of fatigue in patients with prostate cancer undergoing radical external beam radiotherapy and neoadjuvant hormone therapy.
Pauline T Truong, Eric Berthelet, Junella C Lee, Ross Petersen, Jan T W Lim, Paul Blood

Can J Urol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction of systematic setup errors in prostate radiation therapy: how many images to perform?
Joanna J S Ludbrook, Peter B Greer, Paul Blood, Yulia D'yachkova, Andrew Coldman

Med Dosim· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant hormone therapy and external-beam radiation for localized high-risk prostate cancer: the importance of PSA nadir before radiation.
Charles M Ludgate, Darcy C Bishop, Howard Pai, Brenna Eldridge, Jan Lim, Paul Blood

Int J Radiat Oncol Biol Phys· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping the journey of cancer patients through the health care system. Part 3: An approach to staging.
Jeff A Sloan, Shannon Scott-Findlay, Anne Nemecek, Paul Blood, Cheryl Trylinski

Can Oncol Nurs J· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping the journey of cancer patients through the health care system. Part 2: Methodological approaches and basic findings.
Jeff A Sloan, Shannon Scott-Findlay, Anne Nemecek, Paul Blood, Cheryl Trylinski

Can Oncol Nurs J· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping the journey of cancer patients through health care system. Part 1: developing the research question.
Jeff A Sloan, Shannon Scott-Findlay, Anne Nemecek, Paul Blood, Cheryl Trylinski

Can Oncol Nurs J· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15).
Andrea Bezjak, Peter Dixon, Michael Brundage, Dong Tu, Michael J Palmer, Paul Blood

Int J Radiat Oncol Biol Phys· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incorrect biochemistry complicates prostate cancer management.
Iain McAuley, Gary Steinhoff, Michael McNeely, Paul Blood

Can J Urol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis